H.R. 9635 (119th)Legislative Design
To amend the Federal Food, Drug, and Cosmetic Act to establish special rules to provide for continued review of human drug and device submissions during a lapse of appropriations
domestic policy
Current stageCommittee
Referred to the House Committee on Energy and Commerce.
Introduced
Committee
Floor
President
Law
Legislative design
How complete and executable the bill text feels.
iThis page explains why each dimension scored the way it did, and which parts of implementation are explicit versus left to future interpretation.
No legislative design analysis yet for this bill.